Literature DB >> 27414023

The Fatty Kidney: Obesity and Renal Disease.

Manuel Praga1, Enrique Morales.   

Abstract

Obesity-related glomerulopathy (ORG) is characterized by glomerulomegaly accompanied in many patients by lesions of focal and segmental glomerulosclerosis. Slowly increasing subnephrotic proteinuria is the commonest presentation of ORG. Occasionally, massive proteinuria (>5-10 g/day) is detected, but the typical findings of nephrotic syndrome are characteristically absent even in patients with massive proteinuria. Superimposed obesity can fuel the progression of other renal diseases, and a reduced number of functioning nephrons (of congenital or acquired causes) synergizes with obesity to induce end-stage renal disease. Weight loss, either induced by diet or bariatric surgery, and renin-angiotensin blockers are effective treatments to slow progression, but a significant proportion of cases will develop end-stage renal disease.
© 2016 S. Karger AG, Basel.

Entities:  

Keywords:  Angiotensin-converting enzyme inhibitors; Focal and segmental glomerulosclerosis; Hyperfiltration

Mesh:

Year:  2016        PMID: 27414023     DOI: 10.1159/000447674

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  16 in total

Review 1.  A Novel Mechanism of Renal Microcirculation Regulation: Connecting Tubule-Glomerular Feedback.

Authors:  Cesar A Romero; Oscar A Carretero
Journal:  Curr Hypertens Rep       Date:  2019-01-18       Impact factor: 5.369

Review 2.  Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment.

Authors:  Tianhua Xu; Zitong Sheng; Li Yao
Journal:  Front Med       Date:  2017-08-08       Impact factor: 4.592

3.  Proteomic characterization of obesity-related nephropathy.

Authors:  Ralph Wendt; Tianlin He; Agnieszka Latosinska; Justyna Siwy; Harald Mischak; Joachim Beige
Journal:  Clin Kidney J       Date:  2020-04-15

4.  Effect of left or right gastric artery interventional embolization on obesity and ghrelin/leptin expression in pigs.

Authors:  Hui Liu; Xiangying Li; Rihui Chen; Dingcheng Liu; Chao Tong
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

5.  Augmented renal clearance in pediatric intensive care: are we undertreating our sickest patients?

Authors:  Evelyn Dhont; Tatjana Van Der Heggen; Annick De Jaeger; Johan Vande Walle; Peter De Paepe; Pieter A De Cock
Journal:  Pediatr Nephrol       Date:  2018-10-29       Impact factor: 3.714

6.  Obesity Related Metabolic Disorders and Risk of Renal Disease: Impact of Hypocaloric Diet and Avena Sativa Supplement.

Authors:  Salwa M El Shebini; Maha I A Moaty; Suzanne Fouad; Nihad H Ahmed; Salwa T Tapozada
Journal:  Open Access Maced J Med Sci       Date:  2018-07-29

7.  The effects of obesity on kidney function: a challenge for nephrologists.

Authors:  Vera H Koch
Journal:  J Bras Nefrol       Date:  2019-05-30

8.  Educational case: a patient with proteinuria.

Authors:  Christopher N Kassam; Vivian W M Yiu; Meryl H Griffiths; William G Petchey
Journal:  Oxf Med Case Reports       Date:  2020-06-13

9.  Treatment With Gemfibrozil Prevents the Progression of Chronic Kidney Disease in Obese Dahl Salt-Sensitive Rats.

Authors:  Corbin A Shields; Bibek Poudel; Kasi C McPherson; Andrea K Brown; Ubong S Ekperikpe; Evan Browning; Lamari Sutton; Denise C Cornelius; Jan M Williams
Journal:  Front Physiol       Date:  2020-09-18       Impact factor: 4.566

Review 10.  Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities.

Authors:  Lucas Opazo-Ríos; Sebastián Mas; Gema Marín-Royo; Sergio Mezzano; Carmen Gómez-Guerrero; Juan Antonio Moreno; Jesús Egido
Journal:  Int J Mol Sci       Date:  2020-04-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.